(Q38947511)

7 September 2017

title

The effects of oncolytic reovirus in canine lymphoma cell lines (English)

1 reference

7 September 2017

1 reference

1 reference

C C Hwang

1

1 reference

7 September 2017

S Umeki

2

1 reference

7 September 2017

M Igase

3

1 reference

7 September 2017

M Coffey

4

1 reference

7 September 2017

S Noguchi

5

1 reference

7 September 2017

M Okuda

6

1 reference

7 September 2017

T Mizuno

7

1 reference

7 September 2017

publication date

15 October 2014

1 reference

Veterinary and Comparative Oncology

7 September 2017

published in

1 reference

7 September 2017

volume

14 Suppl 1

1 reference

7 September 2017

page(s)

61-73

1 reference

Seasonal distribution of adenoviruses, enteroviruses and reoviruses in urban river water

7 September 2017

cites work

1 reference

Reoviruses in animals other than man.

21 January 2018

1 reference

Seroepidemiology of reovirus in healthy dogs in six prefectures in Japan

21 January 2018

1 reference

Reovirus as an oncolytic agent against experimental human malignant gliomas

21 January 2018

1 reference

Reovirus oncolysis of human breast cancer

21 January 2018

1 reference

Selective reovirus killing of bladder cancer in a co-culture spheroid model.

21 January 2018

1 reference

Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells

21 January 2018

1 reference

Efficacy of oncolytic reovirus against human gastric cancer with peritoneal metastasis in experimental animal model

21 January 2018

1 reference

Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway

21 January 2018

1 reference

The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

21 January 2018

1 reference

Junction adhesion molecule is a receptor for reovirus

21 January 2018

1 reference

Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma

21 January 2018

1 reference

Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release

21 January 2018

1 reference

The staging and treatment of multicentric high-grade lymphoma in dogs: a review of recent developments and future prospects

21 January 2018

1 reference

In vitro canine distemper virus infection of canine lymphoid cells: a prelude to oncolytic therapy for lymphoma.

21 January 2018

1 reference

A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma.

21 January 2018

1 reference

Resistance of canine lymphoma cells to adenoviral infection due to reduced cell surface RGD binding integrins

21 January 2018

1 reference

Reovirus therapy of lymphoid malignancies

21 January 2018

1 reference

Reovirus oncolysis as a novel purging strategy for autologous stem cell transplantation

21 January 2018

1 reference

Establishment and characterization of a canine T-lymphoblastoid cell line derived from malignant lymphoma

21 January 2018

1 reference

Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using real-time polymerase chain reaction

21 January 2018

1 reference

Establishment of five canine lymphoma cell lines and tumor formation in a xenotransplantation model

21 January 2018

1 reference

Establishment and characterization of a new canine B-cell leukemia cell line

21 January 2018

1 reference

Canine lymphoma-associated antigens defined by murine monoclonal antibodies.

21 January 2018

1 reference

Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma.

21 January 2018

1 reference

Oncolytic reovirus in canine mast cell tumor

21 January 2018

1 reference

Reovirus-induced apoptosis requires activation of transcription factor NF-kappaB.

21 January 2018

1 reference

JNK regulates the release of proapoptotic mitochondrial factors in reovirus-infected cells.

21 January 2018

1 reference

Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients.

21 January 2018

1 reference

Conventional apoptosis assays using propidium iodide generate a significant number of false positives that prevent accurate assessment of cell death

21 January 2018

1 reference

Reovirus activates a caspase-independent cell death pathway.

21 January 2018

1 reference

Reovirus modulates autophagy during oncolysis of multiple myeloma

21 January 2018

1 reference

21 January 2018

Oncolytic virotherapy

1 reference

REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancer

21 January 2018

1 reference

Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies

21 January 2018

1 reference

Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms

21 January 2018

1 reference

A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS

21 January 2018

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/OXFORDJOURNALS.AJE.A118408

Identifiers

DOI

10.1111/VCO.12124

1 reference

7 September 2017

1 reference